Resources & News: NSF & Gadolinium
Did MRI Complications Cause Young Man's Death?
Important Drug Warning for Gadolinium-Based Contrast Agents
MedWatch - 2006 Safety Information Alerts
Information on Gadolinium-Containing Contrast Agents
The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI).
- Information for Healthcare Professionals [PDF] [HTML]
- FDA News
- Questions and Answers
Gadolinium-Containing Contrast Agents: Labeling and Regulatory History from Drugs@FDA
